title: Nav Channels in Damaged Membranes.
abstract: Sick excitable cells (ie, Nav channel-expressing cells injured by trauma, ischemia, inflammatory, and other conditions) typically exhibit "acquired sodium channelopathies" which, we argue, reflect bleb-damaged membranes rendering their Nav channels "leaky." The situation is excitotoxic because untreated Nav leak exacerbates bleb damage. Fast Nav inactivation (a voltage-independent process) is so tightly coupled, kinetically speaking, to the inherently voltage-dependent process of fast activation that when bleb damage accelerates and thus left-shifts macroscopic fast activation, fast inactivation accelerates to the same extent. The coupled g(V) and availability(V) processes and their window conductance regions consequently left-shift by the same number of millivolts. These damage-induced hyperpolarizing shifts, whose magnitude increases with damage intensity, are called coupled left shift (CLS). Based on past work and modeling, we discuss how to test for Nav-CLS, emphasizing the virtue of sawtooth ramp clamp. We explain that it is the inherent mechanosensitivity of Nav activation that underlies Nav-CLS. Using modeling of excitability, we show the known process of Nav-CLS is sufficient to predict a wide variety of "sick excitable cell" phenomena, from hyperexcitability through to depolarizing block. When living cells are mimicked by inclusion of pumps, mild Nav-CLS produces a wide array of burst phenomena and subthreshold oscillations. Dynamical analysis of mild damage scenarios shows how these phenomena reflect changes in spike thresholds as the pumps try to counteract the leaky Nav channels. Smart Nav inhibitors designed for sick excitable cells would target bleb-damaged membrane, buying time for cell-mediated removal or repair of Nav-bearing membrane that has become bleb-damaged (ie, detached from the cytoskeleton).
authors: Ottawa Hospital Research Institute, Ottawa, ON, Canada.
authors: C E
authors: CE
authors: Morris
authors: University of Ottawa, Ottawa, ON, Canada.
authors: B
authors: B
authors: Joos
mesh_terms: D000818:Animals; D001768:Blister / Q000473:pathology; D000070642:Brain Injuries, Traumatic / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D053447:Channelopathies / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008564:Membrane Potentials / Q000187:drug effects; D009865:Oocytes / Q000378:metabolism; D061567:Voltage-Gated Sodium Channel Blockers / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D061566:Voltage-Gated Sodium Channels / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*
chemical_list: D061567:Voltage-Gated Sodium Channel Blockers; D061566:Voltage-Gated Sodium Channels
keywords: Acquired sodium channelopathy; Bleb; Excitotoxicity; Hyperpolarizing shift; Inflammation; Ischemia; Mechanosensitivity; Membrane damage; Sick excitable cells; Trauma